Melanoma_Doctor Twitter Feed
- RT @adamfeuerstein: Welcome to #ASCO12 abstract release week
(about 6 days ago)
Featured News
New Feature! “Melanoma Thought of the Day”
0TheMelanomaCenter.com has been a little quiet lately, as the Senior Editor struggles with increased workload, college application assistance, and other obligations that cut down on available time, including readying several [...]
-
ASCO Plenary Part 2: Vemurafenib6
The Melanoma Triple-Threat I was going over my notes about Dr. Paul Chapman’s ASCO [...]
-
ASCO Plenary Part 1: Ipilimumab2
For the second year in a row, melanoma was a featured part of the ASCO [...]
-
ASCO Melanoma Oral Abstract Session1
ASCO Melanoma Oral Abstracts 2011 For the second year in a row, the oral abstract [...]
-
New Drugs and Treatments for Melanoma from ASCO 20111
This year at ASCO will feature, as previously described, two plenary session blockbuster presentations on [...]
-
ASCO 2011 ….. is coming0
The American Society of Clinical Oncology (ASCO) meeting is coming! It begins on Friday [...]
-
General Poster Session ASCO 20100
I went through the general poster session and selected what I thought were the top [...]
-
Discussed Poster Session ASCO 20100
After the relative excitement of the previous two days, the discussed melanoma poster session on [...]
-
Ipilimumab at Plenary Session 20100
Today, for the first time anybody can remember, a melanoma study was presented at the [...]
-
Melanoma Oral Abstracts 20101
For a variety of reasons, I only made it to the Melanoma oral abstract session [...]
-
Diphencyprone (DPCP) as Topical Agent to Treat Melanoma2
This is an inexpensive topical therapy that appears to have some efficacy in regionally advanced [...]
-
Rose Bengal (PV-10) at Melanoma Centers Meeting 20100
Dr. Sanjiv Agarwala presented an update on Phase II trial of PV-10 oncolytic injections (Provectus/Rose [...]
-
Second Line Therapy with BRAF Inhibitor PLX4032/RG72042
This was presented by Dr. Jeff Sosman from Vanderbilt. BRIM-2 trial: n=132 melanoma patients who [...]
-
GSK BRAF Inhibitor With Early But Impressive Results2
Presented by Rick Kefford, MD, from Melanoma Institute of Australia. This was a Phase [...]
-
Overall ASCO summary 20090
I have been going to ASCO for years and I’m still waiting for that “a-hah!” [...]
-
Melanoma Oral Abstracts ASCO 20095
Each year at ASCO there is one and only one session where selected abstracts are [...]
